RetinalGenix Technologies Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
RTGN Over the counter 3841 retinalgenix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for RetinalGenix Technologies Inc.

RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study - Jan 14th, 2026 4:01 am
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO - Dec 8th, 2025 5:43 pm
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases - Oct 16th, 2025 3:01 am
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases - Oct 1st, 2025 4:01 am
RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care - Sep 25th, 2025 4:15 am
RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening - Jun 27th, 2025 1:28 pm
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives - Jun 13th, 2025 3:15 am